Susan Rotzinger
Affiliations: | Cell and Systems Biology | University of Toronto, Toronto, ON, Canada |
Area:
Neuroscience Biology, Endocrinology BiologyGoogle:
"Susan Rotzinger"Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Vaccarino SR, Wang S, Rizvi SJ, et al. (2024) Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder. Bjpsych Open. 10: e18 |
Mazurka R, Cunningham S, Hassel S, et al. (2023) Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 report. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 78: 71-80 |
Rnic K, LeMoult J, Torres IJ, et al. (2023) Predicting recurrence of major depressive episodes using the Depression Implicit Association Test: A Canadian biomarker integration network in depression (CAN-BIND) report. Psychiatry Research. 330: 115606 |
Phaterpekar T, Nunez JJ, Morton E, et al. (2023) Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 Report. The Journal of Clinical Psychiatry. 85 |
Nunez JJ, Liu YS, Cao B, et al. (2023) Response trajectories during escitalopram treatment of patients with major depressive disorder. Psychiatry Research. 327: 115361 |
Schwartzmann B, Quilty LC, Dhami P, et al. (2023) Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study. Scientific Reports. 13: 8418 |
Husain MI, Foster JA, Mason BL, et al. (2023) Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report. Cns Spectrums. 1-28 |
Fu CHY, Erus G, Fan Y, et al. (2023) AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale. Bmc Psychiatry. 23: 59 |
Sajjadian M, Uher R, Ho K, et al. (2022) Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report. Psychological Medicine. 1-11 |
Harris JK, Hassel S, Davis AD, et al. (2022) Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report. Neuroimage. Clinical. 35: 103120 |